{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:42:10Z","timestamp":1761093730029,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":874,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)"},{"name":"\u201cPrograma Interinstitucional de Ensino, Pesquisa e Extens\u00e3o em Biologia do C\u00e2ncer\u201d by Funda\u00e7\u00e3o do C\u00e2ncer"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.bcmd.2010.12.005","type":"journal-article","created":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T04:23:46Z","timestamp":1294460626000},"page":"230-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias"],"prefix":"10.1016","volume":"46","author":[{"given":"Camilla de S.B.","family":"Veiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana C.","family":"Carneiro-Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia J.B.P.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia M.F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel C.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via C.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 L.","family":"Mencalha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fab\u00edola A.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson Q.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.12.005_bb0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-6147(00)01634-5","article-title":"Protease-activated receptors in inflammation, neuronal signaling and pain","volume":"22","author":"Vergnolle","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/MCB.15.2.704","article-title":"Expression cloning of oncogenes by retroviral transfer of cDNA libraries","volume":"15","author":"Whitehead","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm0898-909","article-title":"Thrombin receptor overexpression in malignant and physiological invasion processes","volume":"4","author":"Even-Ram","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0025","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/sj.onc.1206453","article-title":"Role and regulation of the thrombin receptor (PAR-1) in human melanoma","volume":"22","author":"Tellez","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0030","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2559.2008.02978.x","article-title":"Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF","volume":"52","author":"Depasquale","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0002-9440(10)64283-6","article-title":"Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells","volume":"162","author":"Darmoul","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jcb.20533","article-title":"PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism","volume":"96","author":"Tantivejkul","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.20607","article-title":"Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples","volume":"113","author":"Grisaru-Granovsky","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0050","first-page":"1599","article-title":"Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer","volume":"21","author":"Ribeiro","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1096\/fj.02-0316com","article-title":"Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation","volume":"17","author":"Yin","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1541-7786.395.2.7","article-title":"Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis","volume":"2","author":"Shi","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1541-7786.MCR-06-0261","article-title":"Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression","volume":"5","author":"Salah","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0075","doi-asserted-by":"crossref","first-page":"8517","DOI":"10.1016\/S0021-9258(17)37225-3","article-title":"Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production","volume":"269","author":"Mari","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jcp.1041310216","article-title":"Thrombin chemotactic stimulation of HL-60 cells: studies on thrombin responsiveness as a function of differentiation","volume":"131","author":"Bar-Shavit","year":"1987","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5414\/CPP40329","article-title":"Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitro","volume":"40","author":"Schiller","year":"2002","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0090","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0105","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0115","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0120","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.beha.2008.12.007","article-title":"The coagulopathy of acute promyelocytic leukaemia revisited","volume":"22","author":"Stein","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0145-2126(95)00107-7","article-title":"Tissue factor expression in human leukemic cells","volume":"20","author":"Hair","year":"1996","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0135","first-page":"1549","article-title":"Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor","volume":"90","author":"Nadir","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1055\/s-0037-1615959","article-title":"Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoid acid and dibutyryl cAMP","volume":"85","author":"L\u00f3pez-Pedrera","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0145","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1538-7836.2004.00787.x","article-title":"Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia","volume":"2","author":"Tallman","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2010.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/10428190701340616","article-title":"Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia","volume":"48","author":"Barbarroja","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2010.12.005_bb0155","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1538-7836.2009.03553.x","article-title":"Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model","volume":"7","author":"Carneiro-Lobo","year":"2009","journal-title":"J. Thromb. Haemost."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:28:15Z","timestamp":1761049695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1079979610003001"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.12.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}